MPO Staff02.07.22
New View Surgical Inc. is $9 million richer, thanks to a Series B financing round from various investors. Company executives said the money will be used to help commercialize the firm's VisionPort System for minimally invasive surgery, approved last June by the FDA.
“We’re excited to bring this technology to key hospitals and surgical teams that supports our mission to advance the growth of minimally invasive surgical procedures worldwide and holistically address the clinical, operational, and financial needs of the operating room. A majority of funds raised in this round resulted from follow-on investments from current investors, which is a testament to our company’s vision and accomplishments,” President and CEO Bryce Klontz said.
The financing round was led by members of New York Angels with Corza Medical Inc., IAG Capital Partners, Charleston Angels Partners, Ariel Savannah Angel Partners, Keiretsu Forum, Mid Atlantic Bio Angels (MABA) and SSIP, among others. In conjunction with this financing round, the cmpany's Board of Directors will expand to include John Younger, M.D., a member of New York Angels, and Tom Testa, chief financial officer at Corza Medical Inc. Younger and Testa will serve with current board members, Chairman Scott Flora, Melvin Prenovitz, Nancy Briefs, Mark Schneider, and Klontz.
“We are pleased to welcome John and Tom to the Board, and we are excited to welcome several new investors to the New View Surgical family,” Klontz said.
The VisionPort System is a surgical imaging and access system that simplifies laparoscopic procedures by reducing the need for a separate camera port and camera holder and allows multiple simultaneous views of the operative field. In emerging markets, the company expects its VisionPort System to greatly reduce the capital-intensive equipment currently required to perform minimally invasive surgery, and thus, making state-of-the-art technology more accessible. The VisionPort System is intended to be used in a various diagnostic and therapeutic procedures within the thoracic and abdominal cavities and is adaptable to a wide variety of surgical environments, representing a significant market opportunity.
“New View Surgical is taking the bold step to reimagine laparoscopic visualization,” said Younger, managing director at ArgoPond, a life science advisory and capital firm based in Philadelphia.
“The company’s visualization technology will enable less invasive surgery for patients and will make state-of-the-art visualization more accessible to surgeons, regardless of the setting. Multiple members of New York Angels participated in this round and are excited about what the future holds for New View Surgical and the VisionPort System platform,” added Testa. “New View Surgical is taking a holistic approach to adding value and is setting the stage for improved clinical care and operational efficiencies, all while lowering costs.”
New View Surgical is an emerging medical device company focused on developing and commercializing the VisionPort System, which combines multiple imaging and access devices into one simple, easy-to-use disposable device.
“We’re excited to bring this technology to key hospitals and surgical teams that supports our mission to advance the growth of minimally invasive surgical procedures worldwide and holistically address the clinical, operational, and financial needs of the operating room. A majority of funds raised in this round resulted from follow-on investments from current investors, which is a testament to our company’s vision and accomplishments,” President and CEO Bryce Klontz said.
The financing round was led by members of New York Angels with Corza Medical Inc., IAG Capital Partners, Charleston Angels Partners, Ariel Savannah Angel Partners, Keiretsu Forum, Mid Atlantic Bio Angels (MABA) and SSIP, among others. In conjunction with this financing round, the cmpany's Board of Directors will expand to include John Younger, M.D., a member of New York Angels, and Tom Testa, chief financial officer at Corza Medical Inc. Younger and Testa will serve with current board members, Chairman Scott Flora, Melvin Prenovitz, Nancy Briefs, Mark Schneider, and Klontz.
“We are pleased to welcome John and Tom to the Board, and we are excited to welcome several new investors to the New View Surgical family,” Klontz said.
The VisionPort System is a surgical imaging and access system that simplifies laparoscopic procedures by reducing the need for a separate camera port and camera holder and allows multiple simultaneous views of the operative field. In emerging markets, the company expects its VisionPort System to greatly reduce the capital-intensive equipment currently required to perform minimally invasive surgery, and thus, making state-of-the-art technology more accessible. The VisionPort System is intended to be used in a various diagnostic and therapeutic procedures within the thoracic and abdominal cavities and is adaptable to a wide variety of surgical environments, representing a significant market opportunity.
“New View Surgical is taking the bold step to reimagine laparoscopic visualization,” said Younger, managing director at ArgoPond, a life science advisory and capital firm based in Philadelphia.
“The company’s visualization technology will enable less invasive surgery for patients and will make state-of-the-art visualization more accessible to surgeons, regardless of the setting. Multiple members of New York Angels participated in this round and are excited about what the future holds for New View Surgical and the VisionPort System platform,” added Testa. “New View Surgical is taking a holistic approach to adding value and is setting the stage for improved clinical care and operational efficiencies, all while lowering costs.”
New View Surgical is an emerging medical device company focused on developing and commercializing the VisionPort System, which combines multiple imaging and access devices into one simple, easy-to-use disposable device.